The role of inflammation on atherosclerosis

May 1, 2012

(Medical Xpress) -- European scientists dig into atherosclerotic plaque formation processes to investigate the part played by inflammation and vascular wall remodelling.

Cardiovascular diseases remain a serious health problem necessitating an understanding of the underlying mechanisms and the development of novel diagnostic, preventive and therapeutic strategies. Atherosclerosis is caused by a thickening of the capillary walls due to accumulation of lipids such as cholesterol.

Accumulating evidence indicates that inflammation plays a central role in atherosclerosis. To further delineate the causes of atherosclerosis, the EU-funded Atheroremo project has brought together scientists from an array of disciplines.

Project partners have identified some previously unknown involved in vascular inflammation. Their discovery of a novel role of the Streptococcus mitis in atherosclerosis demonstrates that infection can act as a potential initiator of disease. By dissecting the atherosclerotic plaque, researchers have noticed that expression of inflammatory interferons induces changes in the lining the arteries inducing vascular remodelling. A further intriguing discovery has been the involvement of anti-lipoprotein antibodies in atherosclerosis.

Additionally, the consortium has tested a number of novel treatments including montelukast – a compound used in asthma medication – to prevent arterial wall remodelling. Various anti-inflammatory compounds are currently being tried as potential therapeutic strategies.

The Atheroremo project has also joined a large clinical analysis study of patient genetics to discover several new biomarkers for atherosclerosis risk. These novel predictive lipid molecules will form the basis for patient risk assessment.

Overall, the study results to date provide significant information on the inflammatory mechanisms governing atherosclerotic . This knowledge is expected to have serious implications in the diagnosis and therapy of atherosclerosis patients.

Related Stories

Recommended for you

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

New vaccine production could improve flu shot accuracy

July 24, 2017
A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection.

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.